Sotorasib's Accelerated Approval: Wrong Dose and Indication.
Sotorasib's Accelerated Approval: Wrong Dose and Indication. JAMA Oncol. 2025 May 01; 11(5):479-480.
PMID: 40079943
Triaging Acute Chest Syndrome Clinical Decision-Making Using Bedside SaO2/FiO2 Ratio.
Triaging Acute Chest Syndrome Clinical Decision-Making Using Bedside SaO2/FiO2 Ratio. Blood Adv. 2025 Apr 03.
PMID: 40179390
Formulation-Based Cost Savings with Cabozantinib Capsules.
Formulation-Based Cost Savings with Cabozantinib Capsules. JAMA Oncol. 2025 Apr 03.
PMID: 40178839
Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing.
Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing. Clin Transl Sci. 2025 Apr; 18(4):e70193.
PMID: 40259529
Missed Opportunity for Sotorasib Dose Optimization.
Missed Opportunity for Sotorasib Dose Optimization. J Clin Oncol. 2025 Apr 20; 43(12):1518-1519.
PMID: 39913889
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy.
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy. Commun Med (Lond). 2025 Jan 08; 5(1):9.
PMID: 39779996
Non-inferiority trials: tyranny or good governance? - Authors' reply.
Non-inferiority trials: tyranny or good governance? - Authors' reply. Lancet Oncol. 2025 Jan; 26(1):e8.
PMID: 39756458
Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care.
Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care. J Pain Res. 2024; 17:4187-4196.
PMID: 39717756
The tyranny of non-inferiority trials.
The tyranny of non-inferiority trials. Lancet Oncol. 2024 Oct; 25(10):e520-e525.
PMID: 39362263
Dose optimization of sotorasib: Has the burden of proof for the labeled dose been met?
Dose optimization of sotorasib: Has the burden of proof for the labeled dose been met? Eur J Cancer. 2024 Nov; 212:115044.
PMID: 39357278